CAMBRIDGE, Mass., Sept. 11 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today announced plans to offer 8,000,000 shares of its newly issued common stock in an underwritten public offering. Vertex also expects to grant the underwriters a 30-day option to purchase additional shares to cover over-allotments, if any.
